106 related articles for article (PubMed ID: 9709459)
1. Antibodies to oxidized lipoproteins and their relationship to myocardial infarction.
Ryan M; Owens D; Kilbride B; Collins P; Johnson A; Tomkin GH
QJM; 1998 Jun; 91(6):411-5. PubMed ID: 9709459
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
[TBL] [Abstract][Full Text] [Related]
3. [Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty].
Araki T; Kanaya H; Shimizu M; Mabuchi H; Kitayama M; Kanemitsu S; Takekoshi N;
J Cardiol; 2001 Aug; 38(2):55-60. PubMed ID: 11525110
[TBL] [Abstract][Full Text] [Related]
4. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
6. The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
Lopes-Virella MF; Hunt KJ; Baker NL; Virella G; Moritz T;
Atherosclerosis; 2012 Oct; 224(2):526-31. PubMed ID: 22963984
[TBL] [Abstract][Full Text] [Related]
7. The effects of atorvastatin on interventional therapy in patients with acute myocardial infarction.
Wang K; Chen L; Liu L; Cui Y; Zhang X; Jiang J
Minerva Med; 2019 Apr; 110(2):101-106. PubMed ID: 29696937
[TBL] [Abstract][Full Text] [Related]
8. Serum matrix metalloproteinase-9 is elevated in men with a history of myocardial infarction.
Renko J; Kalela A; Jaakkola O; Laine S; Höyhtyä M; Alho H; Nikkari ST
Scand J Clin Lab Invest; 2004; 64(3):255-61. PubMed ID: 15222636
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
10. Effect of acute myocardial infarction on cholesterol ratios.
Wattanasuwan N; Khan IA; Gowda RM; Vasavada BC; Sacchi TJ
Chest; 2001 Oct; 120(4):1196-9. PubMed ID: 11591560
[TBL] [Abstract][Full Text] [Related]
11. Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL).
Motamed M; Nargesi AA; Heidari B; Mirmiranpour H; Esteghamati A; Nakhjavani M
Clin Lab; 2016 Sep; 62(9):1609-1617. PubMed ID: 28164576
[TBL] [Abstract][Full Text] [Related]
12. High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: The Standard versus high-dose therApy with Rosuvastatin for lipiD lowering (SARD) trial.
Nishikido T; Oyama J; Keida T; Ohira H; Node K
J Cardiol; 2016 Apr; 67(4):340-6. PubMed ID: 26162946
[TBL] [Abstract][Full Text] [Related]
13. [Correlations between lipid ratio/oxidative stress status in COPD patients and pulmonary hypertension
as well as prognosis].
Li C; Yan L; Xu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1168-1174. PubMed ID: 27932762
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population.
Tinahones FJ; Gómez-Zumaquero JM; Rojo-Martínez G; Cardona F; Esteva de Antonio IE; Ruiz de Adana MS; Soriguer FJ
Metabolism; 2002 Apr; 51(4):429-31. PubMed ID: 11912548
[TBL] [Abstract][Full Text] [Related]
15. Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction.
Gruzdeva O; Uchasova E; Dyleva Y; Belik E; Karetnikova V; Shilov A; Barbarash O
Lipids Health Dis; 2014 Jul; 13():111. PubMed ID: 25008008
[TBL] [Abstract][Full Text] [Related]
16. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
[TBL] [Abstract][Full Text] [Related]
17. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes.
Kabaroglu C; Mutaf I; Boydak B; Ozmen D; Habif S; Erdener D; Parildar Z; Bayindir O
Acta Cardiol; 2004 Dec; 59(6):606-11. PubMed ID: 15636443
[TBL] [Abstract][Full Text] [Related]
18. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels.
Annema W; Willemsen HM; de Boer JF; Dikkers A; van der Giet M; Nieuwland W; Muller Kobold AC; van Pelt LJ; Slart RH; van der Horst IC; Dullaart RP; Tio RA; Tietge UJ
J Clin Lipidol; 2016; 10(6):1318-1328. PubMed ID: 27919348
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
McDowell A; Young IS; Wisdom GB
J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
[TBL] [Abstract][Full Text] [Related]
20. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
Pawlak K; Mysliwiec M; Pawlak D
Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
